Summary.-The effect has been examined of various host treatments (C. parvum injection, immunization, thoracic irradiation, cyclophosphamide injection, and anticoagulation) on both lung colony formation and clearance of radioactive cells from the lungs after i.v. injection of tumour cells. Two tumour-host models have been used: the non-immunogenic KHT tumour in C3H/Km mice, and the immunogenic EMT6 tumour in BALB/c/Ka mice. Even for the at most weakly immunogenic KHT tumour, the number of artificial pulmonary metastases could be modified by a factor of up to 104 by different host treatments before i.v. inoculation of tumour cells.
For all pretreatments except immunization, the shape of the curve of loss of radioactivity from the lungs vs time was biphasic, with an initial steep portion representing intravascular death of the tumour cells, followed 1-2 days after tumour-cell injection by a shallow exponential curve. It was concluded that the shallow slope represented spontaneous death of tumour cells in the perivascular tissues.
Essentially all the injected tumour cells lodged initially in the lungs, and this was unaffected by the different host treatments. Furthermore, except for specific immunization, cell death in the perivascular tissues was also unaffected by host treatment. However, the survival of the tumour cells during the 24 h after injection (before they became extravascular) was extremely dependent on the particular host pretreatment.
It would appear from these studies that host treatments such as C. parvum injection or anticoagulation can markedly affect the number of blood-borne pulmonary metastases, but they will only be effective if given before the tumour cells arrive in the lung vasculature.
A VARIETY of host treatments have been found markedly to affect the incidence of spontaneous blood-borne metastases, and the number of artificial pulmonary "metastases" arising from an i.v. inoculation of tumour cells. These factors include anticoagulation (Agostino & Clifton, 1962; Brown, 1973a; Hilgard & Thornes, 1976) , corticosteroids (De Brabander et al., 1974) , pulmonary irradiation (Brown, 1973b; Fidler & Zeidman, 1972; Withers & Milas, 1973) , cyclophosphamide (Carmel & Brown, 1977; Steel & Adams, 1977; van Putten et al., 1975) , specific immunization (Fidler et al., 1977; Proctor et al., 1976; Wexler et al., 1975) and nonspecific 46 stimulation of the reticuloendothelial system with agents such as C. parvum (Bomford & Olivotto, 1974; Sadler & Castro, 1976) .
In order to quantitate these effects, many of the above workers have used lung-colony counting after the i.v. injection of a known number of tumour cells, and have invariably found that only a small minority (often <0.1%) of the tumour cells injected into the bloodstream ever form a metastasis, implying that the majority of the injected cells die or become permanently dormant. To determine which of these occurs, and with what kinetics, various investigators have labelled the tumour cells before inoculation with a radioactive marker assumed to stay with the cells until they die. The most commonly used ones have been 51Cr (Withers & Milas, 1973; Bomford & Olivotto, 1974; Fisher & Fisher, 1967; Hilgard et al., 1972) and 1251-labelled iododeoxyuridine (Brown, 1973a, b; Fidler, 1970; Hofer et al., 1969; Peters et al., 1978; Proctor et al., 1976; Glaves & Weiss, 1976) . However, it has been shown that these 2 isotopes give different results, and that the distribution of 51Cr label is not correlated with the distribution of injected live tumour cells, because of extensive reutilization of 5lCr-labelled material (Brown, 1973a; Hofer et al., 1969) . Since IUdR is very weakly reutilized, it is the tumour-cell label of choice.
In those studies using 125IUdR-labelled cells in which the radioactivity in the lungs of mice has been followed for more than 1 day after tumour-cell injection, a biphasic curve with an initial rapid loss of radioactivity within the first 1-2 days, followed by a gradual exponential loss over subsequent days, has been found (Brown, 1973a, b; Liotta & DeLisi, 1977; Liotta et al., 1978; De Ruiter et al., 1976) . It has recently been proposed that the initial rapid loss of radioactivity in the first 1-2 days after injection is due to intravascular death of tumour cells trapped in the lungs, and the slower death rate more than 2 days after injection is due to cell death in the extravascular tissues (Liotta & DeLisi, 1977) .
The present study was in order to determine in what way a variety of agents which affect the yield of artificial pulmonary metastases would also affect the curve for loss of radioactively labelled cells from the lungs. Two tumour systems were chosen (one immunogenic and one nonimmunogenic) and host treatments included specific immunization, cyclophosphamide and C. parvum pre-treatments of the animals. In addition, data from previous studies with warfarin anticoagulation and pulmonary irradiation were analysed in the same manner.
MATERIALS AND METHODS
The mice used in these studies were the inbred strains, C3H/Km and BALB/c/Ka. The mice were bred and housed under specificpathogen-free conditions up to their introduction into experiments at the age of 3-4 months. The tumours used were the KHT sarcoma, syngeneic to C3H/Km mice, and the EMT6 tumour, syngeneic to BALB/c/Ka mice. The KHT sarcoma arose spontaneously at the base of the ear of a C3H/Km mouse in 1962, and has since then been maintained by serial s.c. passage into syngeneic mice. The other tumour used, the EMT6 tumour, was obtained by clonal selection from a mammary tumour, the KHJJ carcinoma, which originated from the transplantation of a hyperplastic alveolar nodule into the mammary fat pad. This tumour has been maintained by alternate passage into BALB/c/Ka mice and in vitro. A full description of the derivation and handling procedures of the EMT6 tumour has been published previously (Rockwell et al., 1972) .
Details of the preparation of cell suspensions of the KHT tumour, the lung-colony assay and radioactive labelling of these cells have been published previously (Brown, 1973a) . In outline, the tumour was made into a single-cell suspension by mincing and by gentle treatment with 0.05% trypsin solution for 15 min. A haemacytometer count of trypan-blue-excluding cells enabled a given number of tumour cells to be injected i.v. into syngeneic C3H mice. Suspensions of radioactive KHT cells were prepared by giving 4 i.p. injections (8 h apart) of 125IUdR (Schwartz/Mann, Orangeburg, N.Y., Ci/mmol) at a dose of 0 5 uCi/g body wt per injection, and 1 h after the 4th injection the mice were killed and a tumour cell suspension prepared as described above, except that the cells received 4 washings to remove any unbound radioactivity. Six mice per experimental point were used in all experiments.
To assay for lung colonies, mice were injected with a known number of KHT tumour cells in a volume of 0-2 ml Hanks' solution, killed 17-18 days later, and their lungs fixed without inflation in Bouin's solution (for 24 h) and then in 95% alcohol. Surface colonies were counted with the aid of a dissecting microscope. Histological examination revealed that all nodules were tumours and that 60-70% of the total number of pulmonary tumours were counted using this technique. In all experiments in which the surface lung colonies were counted, 12 mice per point were used.
For the EMT6 tumour, the only modification on the previously published description (Rockwell et al., 1972) is that the tumour line used has been adapted for efficient growth in the lungs by alternating passage in vivo (by i.v. inoculation into BALB/c mice) and in vitro. It is thus designated the EMT6/St/lu line. All details of the lung colony assay and radioactive counting of the EMT6 cells are as described above, with the exception that the EMT6 cells were labelled with '25IUdR in vitro. EMT6 cells in exponential growth were given growth medium containing '25IUdR at a concentration of 0-2 ,uCi/ml.
After 24 h, the medium was removed, the cells harvested by trypsinization and washed x 4 before injection into recipient BALB/c mice. As with the KHT cells, the lungs of the mice were removed at various times after injection, fixed in acetic alcohol, given 2 changes of 70% alcohol (to remove any acidsoluble fraction) and the organs were counted in a gamma counter (Beckman, Biogamma II). The maximum reduction in the number of lung colonies was not critically dependent on the C. parvum dose: a similar 100-fold reduction in the number of lung colonies was found when doses of 1-4 mg-0-1 mg/mouse of C. parvum were injected 4 days before injection of KHT cells. to those from control mice in the same experiment. Although there were 100-fold fewer EMT6 colonies in the C. parvumtreated mice, the average size of the colonies was not different between the two groups.
There have been various other treatments of the host before i.v. inoculation of the tumour cells, the results of some having been published previously (Brown, 1973a, b; Carmel & Brown, 1977) . For completeness Table I shows the results of various experiments with the KHT and EMT6 tumours over a period of 4 years in which these host treatments were given.
Besides the previously discussed C. parvum data, these results indicate that:
1. The KHT sarcoma is non-immunogenic or only weakly immunogenic compared to the strongly immunogenic EMT6 tumour.
2. Prior treatment of recipient mice with cyclophosphamide can increase the number of lung colonies arising from a (Carmel & Brown, 1977) .
$ Local thoracic irradiation (2000 rad) 48 h before tumour-cell injection (Brown & Marsa, 1978) .
** Warfarin in drinking water for 4 days before and 3 days after tumour-cell injection. The concentration of sodium warfarin (Coumadin, Endo Laboratories Inc., Garden City, N.Y.) in the drinking water was adjusted to maintain the prothrombin times at 2-4 x normal by alternating every 2 days between 7-5 mg/l and 5.0 mg/l (Brown, 1973a) . given injection of tumour cells by a factor of 10-100. 3. Local thoracic irradiation enhances the number of lung colonies by a factor of up to 20 for the KHT sarcoma.
4. Warfarin anticoagulation can reduce the number of lung colonies by a factor of 3-6.
5. The presence of a growing primary KHT tumour does not affect the number of lung colonies arising from an i.v. inoculum of KHT cells.
Thus it is apparent that the above range of host treatments preceding a cell inoculum can alter the cloning efficiency (number of lung colonies/no. cells injected) by a factor of , 104, even for the non-immunogenic KHT tumour. It was in order to see how these changes would affect the kinetics of cell removal from the lungs that the labelled-cell studies were performed.
Studies with labelled KHT cells
As an initial check of the relationship between lung radioactivity and the presence of intact tumour cells, an experiment was performed in which a suspension of labelled KHT cells was divided into 4 groups. The first group of cells was sterilized by radiation (10,000 rad) the second was heat-killed (56°C for 1 h) and the third was killed by fixation in formalin, the fourth group remaining as a control. Each group was then washed to remove unbound radioactivity and 2 x 106 labelled cells from each of the 4 groups were injected into recipient C3H mice, and the lungs counted at intervals. Table II shows the results. It is apparent that at 1-2 days after injection no significant radioactivity can be detected in any of the groups in which the cells were killed before injection. This demonstrates that labelled products released from dying cells are not retained in the lungs, i.e. reutilization of label is negligible. Thus the radioactive count is proportional to the number of intact (presumably viable) tumour cells at times beyond 1 day after iujection.
A similar result was not obtained with 51Cr-labelled tumour cells in this case there was little or no difference in the retention of radioactivity by the lungs from animals injected with live or radiation-sterilized cells (data not shown). Fig. 4 shows the results of 2 experiments in which the loss of radioactivity from the lungs of C13H mice was examined in mice injected with saline, cyclophosphamide or C. parvurn before injection of 2 x 106 125IUdR-labelled KHT cells. Best-fitting least-squares regression lines have been fitted to all the data from 1 day after injection. These results showed the following:
1. There was no significant difference between the radioactivity in the lungs 5 min after injection of any of the groups: essentially all (80% + ) of the activity was initially trapped in the lungs.
2. No group had a final slope of the bestfitting line for data beyond 1 day after injection which was significantly different from that of any other group. In other words, the death or loss of cells later than 1 day after injection was the same in the We have published previously similar experiments with KHT cells, in which the recipient animals were either anticoagulated before injection (Brown, 1973a) or received local thoracic irradiation before injection (Brown, 1973b 2-3+0-3 2-5+0-1 2-5 + 0-2 2-7+0-2 2-3+0-3t 2-6 + 0-3 2-3+0-3t 2-0+0-4 * The relatively low initial trapping seen in this experiment was probably due to inadequate removal of unbound radioactivity.
t Calculated from pooled data from 3 consecutive experiments (data shown in Fig. 4 ).
difference in the period 0 to 24 h after injection) we have included the data for the initial trapping and the final slopes from these experiments with a summary of the ones presented here (Table III) . It is apparent from this summary of the results obtained from different experiments on the clearance of KHT cells from the lungs and that for the eventual number of lung colonies formed (Table I ) that neither the percentage of cells initially trapped in the lung nor the slope of the terminal portion of the radioactive-loss curve are affected by host treatments which modify the number of lung colonies by a factor of up to 104.
Studies with labelled EMT6 cells Fig. 5 shows the results of an experiment in which mice were pretreated either with saline, cyclophosphamide or C. parvum before injection of 2 x 106 125IUdR-labelled EMT6 cells. Again, it was found that the initial number of cells trapped was close to 100% in all instances, and that the slopes of the lines fitted from 2 days onwards were not significantly different from each other. Thus, as before, cyclophosphamide and C. parvum pre- 
DISCUSSION
Two principal conclusions can be drawn from the data from these experiments. Firstly, pre-treatment of the host with agents which alter the clonogenicity of both the non-immunogenic KHT and the immunogenic EMT6 tumour over a range of 10,000, makes little or no difference to the initial number of cells trapped in the lungs: in all cases, close to 1000% of the cells are initially trapped in the lungs after a single i.v. injection of the tumour cells. Secondly, except for specific immunization, all the host treatments which affected the incidence of lung colonies produced no differences in the final slopes of the radioactive-loss curve: almost all the differences between the different treatments occurred in the period 5 min to 24 h after tumour-cell injection.
The first conclusion--that host treatments do not affect the initial arrest of tumour cells in the lungs-was also reached by Fidler et al. (1977) for the case of various immunological modifications of the tumour-host status, by Peters et al. (1978) for local thoracic irradiation and previously by ourselves for anticoagulation and lung irradiation (Brown, 1973a, b) . This conclusion, however, is at variance with the work of WVeiss and co-workers (Weiss et al., 1974; Glaves & Weiss, 1976) who have concluded that immunological modifications of the host against the tumour affects the initial pattern of arrest after i.v. injection of tumour cells. Their conclusions, however, are all based on the radioactive count I h after injection and, from the present data and that of others (Fidler et al., 1977) by 1 h significant loss of radioactivity from the lungs has already occurred. Thus it is possible that the differences measured by Weiss and colleagues reflect differences in the killing of trapped cells rather than differences in the initial arrest.
The rapid loss of radioactivity in the first few hours after cell injection has been observed by all workers in the field. This loss of radioactivity could be due either to death of tumour cells within the lungs (and subsequent elimination of radioactive cell debris) or to the passage of intact tumour cells from the pulmonary vessels into the heart, to be distributed systemically. We investigated the latter possibility by injecting EMT6 tumour cells directly into the left heart of mice which were either untreated or had been treated with cyclophosphamide l day before injection. The results (Table IV) demonstrate that, in mice killed 17 days after injection, no colonies are found in organs other than the lungs if the injection is i.v., but colonies can be seen in the liver and kidneys after injection of 10-fold fewer live tumour cells via the iiitracardiac route. This demonstrates that little if any of the initial loss of radioactivity from the lungs could be due to the reseeding of live cells elsewhere in the body. The same conclusion was reached both by Proctor et al. (1976) and by Peters et al. (1978) using different bioassay procedures for the blood collected from the abdominal aorta. Thus it seems reasonable to conclude that essentially all ( > 90°u) of the loss of radioactivity from the lungs in the first 24 h after cell injection is due to death of tumour cells trapped in the lungs, and not to reseeding of viable cells elsewhere.
If death of the trapped tumour cells occurs in the lungs, the question arises as to the precise anatomical location of this death. It is now generally accepted that for the majority of tumours the trapped cells must migrate through the walls of the blood vessels into the perivascular tissues before they can start to proliferate and become metastases. This conclusion derives primarily from the elegant microcinematographic studies of tumour cells in the rabbit ear chamber by Wood and colleagues (Johnson & Wood, 1963; Wood, 1964 Wood, , 1971 and from several lightand electron-microscopic studies (Chew & Wallace, 1976; Jones et al., 1971; Ludatscher et al., 1967; Sindelar et al., 1975) . These morphological studies have shown that the migration of tumour cells out of the blood vessels can occur between 22 h and 3 days after attachment (Wood, 1964, 1971; Sindelar et al., 1975) . However, probably the most extensive of the morphological studies are those performed by Wallace and colleagues (Jones et al., 1971; Chew & Wallace, 1976) and these authors, working with the Walker 256 tumour in Sprague-Dawley rats, concluded that those tumour cells which leave the pulmonary vasculature do so between 12 and 36 h after attachment. They also concluded that most tumour cells seem to perish intravascularly.
Thus the time scale of attainment of an extravascular position for tumour cells attached to the endothelial wall is similar to that for the initial steep loss of radioactivity from the lungs (i.e. the first 24 h after i.v. injection). We have, both by light and electron microscopy, obtained preliminary confirmation with the KHT tumour system of the same morphological events and timing as described; we can detect large platelet-rich thrombi in blood vessels adjacent to tumour cells, and also the attainment of an extravascular position of tumour cells within 6 h of injection. We also found, as reported by Chew & Wallace (1976) Commerford (1965) has shown that incorporated 125IUdR is extremely stable, free 1251 being released from DNA which had incorporated 125IUdR only after cell death. Thus this does not appear to be a reasonable possibility.
Killing of cells by their incorporated radioactivity
It is possible that the exponential loss of radioactivity from 1 to 2 days could be due to cytotoxicity produced by the incorporated radioactivity. This possibility was checked by determining the number of colonies produced by i.v. injection of 104 live and 5 x 106 heavily irradiated KHT cells, the cells being either radioactively labelled or unlabelled.
The mean number of colonies in the 2 groups was 102+ 11 and 112+8 for the radioactive and non-radioactive cell injections respectively. Thus there was little or no cytotoxicity of the label, as judged by this assay.
Immunoloyical attack
Although it can be seen from Fig. 6 that the immune response can increase significantly the slope of the exponential portion of the radioactive loss curve, it is unlikely that the slope of the line in the absence of prior immunization is due to killing of tumour cells by this specific immune response. The two reasons for this are firstly that the loss starts within 2 days of injection, which is too soon for an immune response to have developed, and secoiidly because the loss occurs not only with the immunogenic EMT6 tumour but also with the non-immunogenic KHT tumour.
5. Cell death due to lack of nutrients Since loss of radioactivity begins I to 2 days after injection, when the micro-metastases could onily be a few cells in size, and therefore too small to possess regions inadequately supplied with nutrients, it is highly unlikely that this could be responsible for cell death within the tumours.
Since none of the above mechanisms satisfactorily explains the exponential loss of radioactivity 1-2 days after injection, we must conclude that the loss of radioactivity from these micrometastases is due either to a spontaneous death rate of the tumour cells (apoptosis) or to the existence within the host of cells with a natural cytotoxicity which is unaffected by the host treatments studied. From a further series of experiments in which we have examined loss of radioactivity from solid tumours and from EMT6 cells in (1977) who found a large increase in lung colonies when the mice had been pre-treated with cyclophosphamide, also pointed out that there was no difference in the size distribution of colonies in treated and untreated recipients. The data for C. parvum pretreatment (Fig. 3) as well as (unpublished) observations with cYclophosphamide, thoracic irradiation and anticoagulation of animals before cell injection, are in agreement with this. However, with specific immunization of the host before cell inoculum, in those experiments in which occasional EMT6 lung colonies were seen, the size of the colonies was very much less than in untreated recipients. It would thus appear that the size distribution of colonies indicates whether the slope of the radioactive-loss curve more than 1-2 days after injection is the same or different from controls.
It can be seen from a comparison of the effect of host treatments on the number of metastases (Table I ) and the corresponding effects on the radioactive-loss curves (Figs. 4 and 5) that the factors by which these host treatments affect the incidence of metastases are greater than those for the radioactive-loss curves. For example, the difference between the cloning efficiency for the KHT sarcoma in mice pretreated either with C. parvum or with cyclophosphamide is approximately a factor of 104, whereas the difference in cell killing in the first 24 h observed from the radioactive-loss curve (Fig. 4) is only a factor of 1]00. The explanation for this discrepancy rests on the fact that different numbers of cells were injected for each of the end-points: for the radioactive-loss curves, 2 x 06 radioactive cells were injected, whereas to obtain lung colonies fewer cells by a factor of 10 to 500 are used. As we have noted for the KHT tumour (Brown & Marsa (1978) and Peters et al. (1978) have documented extensively) both the cloning efficiency and the radioactivity remaining in the lungs at 24 h decline markedly when fewer cells are injected. Thus, if the cell retention after injecting large numbers of cells is between 1 and 10% after 24 h, it is clearly impossible for cyclophosphamide to increase this by a factor of 100. Such a factor, however, can and does occur when the cell number and the cloning efficiency are lower. Conversely, it also appears, as has been previously pointed out with anticoagulation (Brown, 1973a) that the effect of a host treatment which reduced lung colonies is less when large numbers of cells (106-5 x 106) are given. In fact the effect of anticoagulation on the initial cell death and on the eventual numbers of colonies is identical wlhen the same number of cells is given in each case (Brown, 1973a) .
Finally, an important implication can be drawn from the radioactive clearance curve for C. parvum-treated mice. Although it is clear from Figs 1 and 2 that C. parvurn is active over a long period, it is clear from the radioactive-loss curves for both the KHT and EMT6 tumours that C. parvurn has no effect on tumour cells once they have left the vascular lumen. It is also seen in Figs 1 and 2 that there is little or no influence of C. parvurm given 1-2 days after cell inoculation. Thus we conclude that in the absence of a specific immune response (which C. parvum could conceivably enhance) there will be no effect of C. parvurn on micrometastases which have already become extravascular. These data are essentially in agreement with the findings of Bomford & Olivotto (1974) on the influence of timing on the effect of C. parvum on ltunig-nodule formation after i.v. injection of tumour cells. The conclusions are also consistent with the work of Sadler & Castro (1976) who observed a reduction in spontaneous metastases from the Lewis lung carcinoma only when C. parvurn was given 3 to 4 days before amputation of the primary tumour. Hewitt & Blake (1978) have also reported no influence of C. parvum inoculation on spontaneous metastases from two nonimmunogenic tumours. Our data suggest that C. parvum will only be effective against spontaneous metastases if given before seeding tumour cells in the lungs. Since Hewitt & Blake (1978) only tested C. parvum 4 days before surgical removal of the primary tumours, it is likely that by this time micrometastases were already developing in the mice and therefore beyond the reach of C. parvum treatment. Thus these results, together with those of Sadler & Castro (1976) and Hewitt & Blake (1978) demonstrate that for nonimmunogenic tumours C. parvum will only be effective in preventing or reducing metastatic spread which occurs after the C. parvurn treatment. 
